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Introduction
Genital lichen sclerosus (LS) is a chronic inflammatory
disease usually managed with intermittent potent topical
corticosteroids.5% of women with untreated vulval LS
go on to develop squamous cell carcinoma (SCC).
Current guidelines from the British Association of
Dermatologists (BAD) state that patients on topical cor-
ticosteroids should be reviewed at least annually by their
General Practitioner (GP) [1]. Previous work has shown
that many women discharged from secondary to pri-
mary care are lost to follow-up [2].
Methoda
An anonymised questionnaire was sent to sixty women
with genital LS discharged from our regional vulval clinic
more than a year previously. Caldicott Guardian approval
was obtained for the study.
Results
Forty-five patients (75%) returned the questionnaire.
Seventy one percent of patients had not attended their GP
for follow-up. Of the 17 patients who had seen their GP,
only 7 had had their vulval area examined. Only 53% of
patients self-examined their vulval area. 48% were not
aware of the need to report any area of persistent abnorm-
ality to their GP. 28 patients were still using topical corti-
costeroid - 24 of these potent or ultrapotent steroid. 48.9%
of all respondents thought a 30g tube of strong steroid
should last a year, 26.7% three months, 13.3% one month
and 11.1% were unsure. Only 30 patients (66.7%) were
aware of the increased risk of skin cancer associated with
vulval LS, the remainder being unaware or uncertain.
Conclusions
Our study has highlighted worrying deficiencies in the
long-term follow-up of this patient group. We have
devised a brief patient information leaflet to be provided
to both the patient and their GP at discharge to detail
the small increased cancer risk, the need for monthly
self-examination, clear instructions on the use of topical
corticosteroids and the need for annual review by their
GP. Hopefully, this will lead to an increased quality of
patient care. We then plan to repeat the audit after an
appropriate time interval.
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